How is gut microbiome of patients with familial adenomatous polyposis different from healthy people?

Author:

Kim Jae Hyun1ORCID,Kim Yeon Ji2,Oh Gyu Man1,Jung Woohyuk1,Park Seun Ja1

Affiliation:

1. Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea

2. Institution of Gastroenterology, Kosin University College of Medicine, Busan, Korea.

Abstract

The gut microbiome has been increasingly suggested as an underlying cause of various human diseases. In this study, we hypothesized that the gut microbiomes of patients with familial adenomatous polyposis (FAP) are different from those of healthy people and attempted to identify the associations between gut microbiome characteristics and FAP. We collected fecal samples from patients with FAP and healthy volunteers and evaluated the diversity, composition, and distribution of the gut microbiome between the 2 groups via 16S rRNA-based taxonomic profiling of the fecal samples. Fecal samples were collected from 10 patients with FAP (4 men and 6 women, mean age 39.2 ± 13.8 years) and 10 healthy volunteers (4 men and 6 women, mean age 40.9 ± 9.8 years). The microbial richness in patients with FAP was significantly lower than that in healthy people. Regarding microbial composition, the Firmicutes/Bacteroidetes ratio in patients with FAP was higher than that in healthy people, especially in those with a lower proportion of Bacteroidetes and a higher proportion of Proteobacteria. We also found 7 specific abundant strains in fecal samples of patients with FAP. Patients with FAP had different Firmicutes/Bacteroidetes ratios and Proteobacteria abundance compared to healthy people and showed the presence of specific bacteria. These findings suggest a promising role of the gut microbiome in patients with FAP, although further studies are needed.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference30 articles.

1. Molecular diagnosis of familial adenomatous polyposis.;Powell;N Engl J Med,1993

2. The genetic basis of familial adenomatous polyposis and its implications for clinical practice and risk management.;Leoz;Appl Clin Genet,2015

3. Guidelines for the clinical management of familial adenomatous polyposis (FAP).;Vasen;Gut,2008

4. Hereditary cancer syndromes as model systems for chemopreventive agent development.;Walcott;Semin Oncol,2016

5. Richness of human gut microbiome correlates with metabolic markers.;Le Chatelier;Nature,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3